- Home
- ARWR vs LADR Comparison
ARWR vs LADR Comparison
Compare ARWR & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- LADR
- Stock Information
- Founded
- ARWR 2003
- LADR 2008
- Country
- ARWR United States
- LADR United States
- Employees
- ARWR N/A
- LADR N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- LADR Real Estate Investment Trusts
- Sector
- ARWR Health Care
- LADR Real Estate
- Exchange
- ARWR Nasdaq
- LADR Nasdaq
- Market Cap
- ARWR 1.8B
- LADR 1.5B
- IPO Year
- ARWR 1993
- LADR 2014
- Fundamental
- Price
- ARWR $16.07
- LADR $10.51
- Analyst Decision
- ARWR Buy
- LADR Buy
- Analyst Count
- ARWR 10
- LADR 6
- Target Price
- ARWR $42.13
- LADR $13.17
- AVG Volume (30 Days)
- ARWR 1.9M
- LADR 572.3K
- Earning Date
- ARWR 05-12-2025
- LADR 07-24-2025
- Dividend Yield
- ARWR N/A
- LADR 8.74%
- EPS Growth
- ARWR N/A
- LADR 7.86
- EPS
- ARWR N/A
- LADR 0.82
- Revenue
- ARWR $545,209,000.00
- LADR $259,161,000.00
- Revenue This Year
- ARWR $4,380.43
- LADR N/A
- Revenue Next Year
- ARWR $66.56
- LADR $14.82
- P/E Ratio
- ARWR N/A
- LADR $12.84
- Revenue Growth
- ARWR 1436.97
- LADR 1.39
- 52 Week Low
- ARWR $9.57
- LADR $9.68
- 52 Week High
- ARWR $30.41
- LADR $12.48
- Technical
- Relative Strength Index (RSI)
- ARWR 59.58
- LADR 50.45
- Support Level
- ARWR $14.92
- LADR $10.03
- Resistance Level
- ARWR $17.19
- LADR $10.77
- Average True Range (ATR)
- ARWR 0.95
- LADR 0.18
- MACD
- ARWR 0.11
- LADR 0.01
- Stochastic Oscillator
- ARWR 70.29
- LADR 62.34
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.